Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houdart, E.
Right arrow Articles by Merland, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houdart, E.
Right arrow Articles by Merland, J.-J.
Neurology 2001;56:1582-1584
© 2001 American Academy of Neurology
Brief Communications

Thrombolysis of extracranial and intracranial arteries after IV abciximab

E. Houdart, MD;, F. Woimant, MD;, R. Chapot, MD;, C. Mounayer, MD;, C. Soria, MD, PhD; and J.–J. Merland, MD, PhD

From the Departments of Neuroradiology and Therapeutic Angiography (Drs. Houdart, Chapot, and Mounayer), Neurology (Dr. Woimant), and Hematology (Dr. Soria), Hôpital Lariboisière, Paris, France.

Address correspondence and reprint requests to Dr. Emmanuel Houdart, Service de Neuroradiologie et d’Angiographie Thérapeutique, Hôpital Lariboisière, 2 rue Ambroise Paré, 75010 Paris, France; e-mail: ehoudart{at}compuserve.com

Abciximab was administered intravenously to three patients to treat thrombus associated with atherosclerotic stenosis of a supra-aortic artery. In two cases, the thrombi had been identified on a previous angiography more than a week before treatment. Successful thrombolysis was achieved with abciximab in all three cases. In this small series, abciximab had a thrombolytic effect on established thrombi that were refractory to previous antithrombotic treatment attempts.




This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
C. Mounayer, M. Piotin, S. Baldi, L. Spelle, and J. Moret
Intraarterial Administration of Abciximab for Thromboembolic Events Occurring during Aneurysm Coil Placement
AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 2039 - 2043.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
B. Eckert, C. Koch, G. Thomalla, J. Roether, and H. Zeumer
Acute Basilar Artery Occlusion Treated With Combined Intravenous Abciximab and Intra-arterial Tissue Plasminogen Activator: Report of 3 Cases
Stroke, May 1, 2002; 33(5): 1424 - 1427.
[Abstract] [Full Text] [PDF]